首页> 外国专利> isolated compound, pharmaceutical composition, method of treating or preventing at least one of the following diseases, disorders or conditions, and method of treating or preventing a circadian rhythm disorder or circadian component disorder in an individual

isolated compound, pharmaceutical composition, method of treating or preventing at least one of the following diseases, disorders or conditions, and method of treating or preventing a circadian rhythm disorder or circadian component disorder in an individual

机译：分离的化合物，药物组合物，治疗或预防以下疾病，病症或病状中的至少一种的方法以及治疗或预防个体的昼夜节律紊乱或昼夜节律成分紊乱的方法

页面导航

摘要
著录项
相似文献

摘要

Isolated metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]-methyl]propanamide, methods for their use, and compositions containing the metabolites.

机译：（1R-反式）-N-[[2-（2，3-二氢-4-苯并呋喃基）环丙基]-甲基]丙酰胺的分离代谢物，其使用方法以及含有该代谢物的组合物。

著录项

公开/公告号BR112014028446A2

专利类型
公开/公告日2017-10-24

原文格式PDF
申请/专利权人 VANDA PHARMACEUTICALS INC.;
展开▼

申请/专利号BR20141128446
发明设计人 DEEPAK PHADKE;MARLENE MICHELLE DRESSMAN;
展开▼

申请日2013-05-17
分类号A61K31/195;A61K31/165;A61P25;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;C07C233/18;C07C233/47;
国家 BR
入库时间 2022-08-21 13:40:23

相似文献

专利
外文文献
中文文献